The Canadian Cancer Society (CCS) and the Canadian Breast Cancer Foundation (CBCF) today announced plans to merge in order to have a greater impact on cancer research and support programs across Canada. The two national health charities plan to come together under the Canadian Cancer Society banner. The mandate and spirit of the Canadian Breast Cancer Foundation, including its key programs and activities, will remain a vital and important part of the Canadian Cancer Society.
The Canadian Cancer Society also announced the appointment of Lynne Hudson as President and CEO, effective immediately. Hudson is CEO of the Canadian Breast Cancer Foundation and has extensive experience in change management, strategic planning, fundraising and development in the corporate and non-profit sectors in Canada and the U.S. She will lead both CBCF and the Canadian Cancer Society through the amalgamation.
“Put simply, we are stronger together,” said Robert Lawrie, Chair of the Canadian Cancer Society Board of Directors. “The impact of each of these two organizations is substantial, and bringing them together will have so many benefits for Canadians. It will improve our performance, increase opportunities, reduce costs, expand resources, enhance advocacy efforts and allow more funds to be directed to cancer research and support.”
By 2030, the number of cancer cases in Canada is expected to rise by 40 per cent, driven largely by the aging population. This surge in cancer cases will bring with it increasing demand for services, programs and research.
“This amalgamation is timely and will help meet increased demands for support and research and advance our shared vision of a world where no Canadian fears cancer,” said Valerie Steele, Chair of the CBCF Board of Directors. “This is wonderful news for the cancer community and for our generous donors.”
“I am delighted to have been asked to lead these outstanding organizations through such a pivotal transformation that will accelerate our ability to make a meaningful difference in the fight against cancer,” said Lynne Hudson. “Together, CCS and CBCF have invested more than $1.5 billion in life-saving cancer research over the course of their histories. Just imagine what we can accomplish together.”
The proposed merger is expected to be finalized by February 1, 2017, and still requires the completion of due diligence and appropriate approvals, including CRA. In the meantime, each organization will continue to operate as usual.
The Canadian Cancer Society is a national, community-based organization of more than 140,000 volunteers whose mission is to eradicate cancer and enhance the quality of life of people living with the disease. Thanks to our donors and volunteers, the Society has the greatest impact, against all cancers, in the most communities in Canada. For more information, visit cancer.ca or call the toll-free bilingual Cancer Information Service at 1-888-939-3333 (TTY 1-866-786-3934).
The Canadian Breast Cancer Foundation (CBCF) is a national community-driven charity. As the largest charitable funder of breast cancer research in Canada, CBCF’s vision is to create a future without breast cancer. Since its inception in 1986, the Foundation has invested over $360 million in breast cancer research, funding more than 1,400 scientific and community grants. CBCF’s investments in vital research, education, health promotion, support and information programs have led to progress in breast cancer prevention, diagnosis, treatment and care. For more information, visit cbcf.org.